Related Experiment Videos
Scoring method for identifying patients with Kawasaki disease at high risk of coronary artery aneurysms
Insights
A new scoring system helps identify children with Kawasaki disease at high risk for coronary artery issues. Early intervention with immunoglobulin therapy can significantly reduce severe coronary lesions in these patients.
Area of Science:
- Pediatrics
- Cardiology
- Immunology
Background:
- Kawasaki disease can lead to coronary artery aneurysms.
- Immunoglobulin therapy is beneficial but should be targeted to high-risk patients.
- Predicting high-risk patients requires effective clinical and laboratory markers.
Purpose of the Study:
- To develop a simple scoring method for evaluating Kawasaki disease severity.
- To identify early clinical and laboratory predictors of coronary artery disease in Kawasaki disease.
- To assess the efficacy of immunoglobulin therapy in preventing coronary complications.
Main Methods:
- Multivariate analysis of clinical and laboratory data from 78 Kawasaki disease patients.
- Development of a scoring system based on age, C-reactive protein, and platelet count.
- Retrospective validation of the scoring system and assessment of treatment outcomes.
Main Results:
- Age at onset, C-reactive protein, and platelet count significantly predicted coronary artery involvement.
- The developed scoring system identified patients at high risk for coronary lesions.
- No patients receiving immunoglobulin therapy experienced moderate or severe coronary lesions.
Conclusions:
- A simple scoring method effectively predicts high-risk patients with Kawasaki disease.
- Targeted immunoglobulin therapy can reduce severe coronary artery complications.
- This scoring system aids in selective immunoglobulin administration for Kawasaki disease management.
Abstract:
The beneficial effect of immunoglobulin in preventing coronary artery aneurysms in patients with Kawasaki disease is recognized, but immunoglobulin should be selectively given to patients at high risk for coronary lesions. The present study was designed to present a scoring method to evaluate the severity of Kawasaki disease in terms of coronary artery disease based on clinical and early laboratory findings. Seventy-eight patients who were admitted at 4 to 7 days of illness and who had received aspirin alone during the acute febrile period were separated into 2 groups according to significant coronary artery involvement, and possible related factors to the discrimination of the 2 groups were studied using multivariate analysis. Age at onset, C-reactive protein and platelet count contributed significantly to the discrimination, and from these 3 items a simple scoring system was devised to predict patients at high risk for coronary lesions. Retrospective study using this scoring method indicated that significant coronary artery disease was more often seen in patients predicted to be at high risk treated with aspirin, while no patients who received immunoglobulin had coronary lesions of moderate or severe degree. Thus, the present scoring method provides simple but clinically useful criteria for predicting patients at high risk of coronary artery disease, and immunoglobulin therapy for selected patients may reduce the significant coronary artery complications of Kawasaki disease.